-
STMicroelectronics and Geely Automobile Group sign a long-term silicon carbide supply agreement and establish a joint laboratory
STMicroelectronics and Geely Automobile Group signed a long-term silicon carbide supply agreement and established a joint laboratory. STMicroelectronics and Geely Automobile Group announced on June 4 ... -
Extreme Krypton breaks the record for the fastest IPO of a new car making force, and "Geely" expands its capital territory again
With the listing of Jike, "Big Geely" is accelerating its expansion of its capital territory. According to a reporter from China Business Daily, the new car making force, Jike, officially listed on t ... -
Gilead Science: Total product sales in the first quarter increased by 5% year-on-year to 6.6 billion US dollars
Securities Times e-Company News: Geely Technology released its financial report for the first quarter of 2024, with a total product sales of 6.6 billion US dollars, a year-on-year increase of 5%. Amo ... -
NIO Energy and Geely Automobile Group Achieve Charging Network Interconnection Cooperation
On March 27th, NIO announced that NIO Energy and Geely Automobile Group have officially reached a cooperation on charging network interconnection. According to the cooperation content, users of Geely ... -
NIO Energy and Geely Automobile Group have officially reached a cooperation on charging network interconnection
On March 27th, according to NIO Auto Weibo, NIO Energy and Geely Automobile Group officially reached a cooperation on charging network interconnection. Users of Geely Automobile, Lynk&Co, Geely Krypt ... -
NIO Energy and Geely Automobile Group Achieve Charging Network Interconnection Cooperation
Securities Times E Company News: According to NIO Auto Weibo, on March 27th, NIO Energy and Geely Automobile Group officially reached a cooperation on charging network interconnection. Users of Geely ... -
Top 10 sales of new energy vehicles in January: Geely and Celes saw a year-on-year surge of 600%
After experiencing price cuts at the end of last year, January is often the off-season for car sales. Recently, major new energy vehicle manufacturers have released their first sales performance repo ... -
Lose the big bet! Gilead's anti-cancer drug trials have shown poor results, and its stock price has plummeted by over 10%
US pharmaceutical giant Gilead announced on Monday that its anti-cancer drug Trodelvy failed to significantly improve survival rates in a trial of advanced lung cancer patients, causing its stock pri ... -
Gilead Science's second HIV pre exposure prophylactic drug has been approved in China, and the awareness rate of PrEP in China is still relatively low
AIDS is a serious disease caused by human immunodeficiency virus (HIV) infection. With the establishment of cocktail therapy and the gradual optimization of treatment plan, AIDS has become a controll ... -
After Chang'an, NIO Geely accelerates the popularization of battery swapping modes from C-end to B-end by holding hands again
Within a week, holding hands with two leading car companies, NIO's battery swapping "friend circle" is rapidly expanding. Following Changan Automobile, NIO and Geely Holding signed a strategic cooper ... -
Geely and NIO sign a cooperation agreement to jointly build a standard system for battery swapping for private and commercial vehicles
Beijing News, Shell Finance News (Reporter Zhang Bing) - After Changan Automobile, Geely has become the second company to cooperate with NIO in the field of battery swapping. On November 29th, Geely ... -
【 Direct Attack on the China International Expo 】 Experience the "Spillover Effect" of China International Expo, Geely's Second Exhibition Expands Its Moments in China
Xinhua Finance and Economics, Shanghai, November 9 (Reporter Du Kang) - Geely Science, a leading global biopharmaceutical company, has embarked on its second "journey to enter the international marke ... -
Gilead Science: In the third quarter, the sales of remdesivir fell 31% year on year
On November 8th, Geely Science released its financial report for the third quarter of 2023 on its official WeChat account. The sales volume of products (excluding remdesivir) increased by 5% year-on- ...